The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax.
- Published in:
- Hemato, 2024, v. 5, n. 3, p. 321, doi. 10.3390/hemato5030024
- By:
- Publication type:
- Article
Works by Mallareddy, Jayapal Reddy
Results: 8
1
2
Transport Characteristics of Endomorphin-2 Analogues in Brain Capillary Endothelial Cells.
- Published in:
- Chemical Biology & Drug Design, 2012, v. 79, n. 4, p. 507, doi. 10.1111/j.1747-0285.2011.01306.x
- By:
- Publication type:
- Article
3
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-07439-0
- By:
- Publication type:
- Article
4
Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.863762
- By:
- Publication type:
- Article
5
Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5506, doi. 10.3390/cancers13215506
- By:
- Publication type:
- Article
6
In vitro pharmacological evaluation of the radiolabeled C-terminal substance P analogue Lys-Phe-Phe-Gly-Leu-Met-NH2: Does a specific binding site exist?
- Published in:
- Folia Neuropathologica, 2014, v. 52, n. 4, p. 383, doi. 10.5114/fn.2014.47839
- By:
- Publication type:
- Article
7
Radiotracers, tritium labelling of neuropeptides.
- Published in:
- ARKIVOC: Online Journal of Organic Chemistry, 2012, p. 163
- By:
- Publication type:
- Article
8
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.87292
- By:
- Publication type:
- Article